Clinical trial
Epidemiology, Prognosis, and Treatment Effectiveness of Asymptomatic Biliary Dilatation
NCT07028164 is registered in ClinicalTrials.gov with Beijing Tsinghua Chang Gung Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Epidemiology, Prognosis, and Treatment Effectiveness of Asymptomatic Biliary Dilatation
- Lead sponsor
- Beijing Tsinghua Chang Gung Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2024
- Completion date
- October 15, 2025
- Enrollment
- 1,008 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.